원격 환자 모니터링 시장 예측(-2032년) : 제공, 전송, 전달 모드, 기술, 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Remote Patient Monitoring Market is accounted for $31.6 billion in 2025 and is expected to reach $80.2 billion by 2032 growing at a CAGR of 14.2% during the forecast period. Remote Patient Monitoring (RPM) is a healthcare practice that uses digital technologies to collect medical data from patients outside of traditional clinical settings. Devices such as wearables, smart sensors, and mobile apps track vital signs, chronic conditions, or treatment progress. This data is securely transmitted to healthcare providers for continuous monitoring and timely intervention. RPM improves patient outcomes, reduces hospital visits, and supports proactive care particularly for individuals managing long-term illnesses or recovering from procedures in home-based environments.

According to a retrospective analysis of Mayo Clinic's COVID-19 remote patient monitoring program, engaged patients had a 30-day mortality rate of 0.5% compared to 1.7% for non engaged patients, and showed significantly lower rates of hospitalization and ICU admission.

Market Dynamics:

Driver:

Rising burden of chronic diseases and aging population

As populations age, healthcare systems are under pressure to manage long-term illnesses more efficiently. Remote patient monitoring offers a scalable solution by enabling real-time tracking of vital signs from home, reducing hospital admissions and improving care coordination. The integration of wearable technologies and mobile health platforms further enhances accessibility and patient engagement. This shift toward proactive care is transforming traditional healthcare delivery models.

Restraint:

Lack of digital literacy and technological adoption among patients

Elderly patients and those in rural or underserved areas often face challenges in using connected devices or navigating telehealth platforms. This digital divide hampers the effectiveness of RPM programs and may lead to underutilization of available tools. Additionally, concerns around data privacy and device usability contribute to hesitation among patients. Bridging this gap requires targeted education, simplified interfaces, and inclusive design strategies.

Opportunity:

Expansion into new therapeutic areas and applications

Remote monitoring is no longer confined to chronic disease management it's expanding into post-operative care, mental health, and infectious disease surveillance. Innovations in biosensors and AI-driven analytics are enabling RPM solutions to support a broader range of clinical scenarios. For example, continuous monitoring of neurological parameters or rehabilitation progress is becoming feasible outside hospital settings. This diversification opens new revenue streams for device manufacturers and service providers, while also enhancing patient outcomes across specialties.

Threat:

Data overload and alert fatigue for clinicians

Frequent alerts especially false positives can lead to desensitization, delayed responses, or missed critical events. This phenomenon, known as alert fatigue, undermines the reliability of monitoring systems and increases the risk of adverse outcomes. To mitigate this, developers are focusing on intelligent algorithms that prioritize actionable alerts and contextualize patient data. However, balancing automation with clinical judgment remains a complex task.

Covid-19 Impact:

The pandemic acted as a catalyst for RPM adoption, highlighting its role in minimizing in-person visits and safeguarding vulnerable populations. While initial supply chain disruptions affected device availability, the surge in telehealth usage and remote consultations drove long-term growth. RPM became essential for monitoring COVID-positive patients at home, managing chronic conditions remotely, and supporting overwhelmed healthcare systems.

The devices segment is expected to be the largest during the forecast period

The devices segment is expected to account for the largest market share during the forecast period due to its foundational role in capturing patient data. From wearable sensors to implantable monitors, these tools provide continuous insights into physiological parameters. Their widespread adoption across hospitals, home care, and ambulatory settings underscores their versatility. Manufacturers are investing in miniaturization, battery efficiency, and interoperability to enhance device performance and user comfort.

The connected / wireless monitoring segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the connected / wireless monitoring segment is predicted to witness the highest growth rate driven by the proliferation of IoT-enabled health devices and mobile connectivity. These solutions allow seamless data transmission to cloud platforms, enabling real-time analytics and remote interventions. The convenience of wireless systems especially in home settings has accelerated patient acceptance and provider adoption.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share attributed to robust healthcare infrastructure and high chronic disease prevalence. The region benefits from favorable reimbursement policies, strong digital health adoption, and active investment in RPM technologies. Leading players in the U.S. and Canada are driving innovation through strategic collaborations and product launches. Additionally, consumer awareness and demand for home-based care are reinforcing RPM's role in mainstream healthcare delivery.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR owing to The region's emphasis on value-based care, coupled with regulatory support for telehealth, is accelerating RPM integration. Advances in AI, cloud computing, and wearable tech are further propelling market expansion. As healthcare providers seek scalable solutions for population health management, RPM is emerging as a cornerstone of digital transformation in the region.

Key players in the market

Some of the key players in Remote Patient Monitoring Market include Welch Allyn, Vivify Health, Tunstall Healthcare, ResMed Inc., Qardio Inc., Philips Healthcare, Medtronic plc, Masimo Corporation, iRhythm Technologies, Honeywell Life Care Solutions, Health Recovery Solutions, GE HealthCare, Care Innovations, Boston Scientific Corporation, BioTelemetry, AMC Health, AliveCor Inc and Abbott Laboratories

Key Developments:

In June 2025, Medtronic announced "MiniMed" as the official name for its upcoming spin-off, the new standalone diabetes care business. This rebranding honors legacy origins and positions the company for focused growth and innovation in diabetes management.

In May 2025, AliveCor launched its flagship AI-powered KardiaMobile 6L Max and introduced KardiaAlert, an advanced ECG monitoring feature for subscribers. This marks its most sophisticated personal ECG system, integrating six-lead AI detection to improve heart rhythm alerts.

In March 2024, Boston Scientific agreed to acquire SoniVie Ltd., a developer of TIVUS(TM) intravascular ultrasound systems for renal denervation. The acquisition enhances the company's interventional cardiology portfolio with novel hypertension treatment devices.

Offerings Covered:

• Devices
• Software
• Services
• Other Offerings

Transmissions Covered:

• Synchronous
• Asynchronous

Mode of Deliveries Covered:

• Connected / Wireless Monitoring
• Standalone Monitoring Systems

Technologies Covered:

• Connectivity Technology
• Data Processing & Analytics
• Monitoring Technology
• Communication Technology
• Interoperability & Integration
• Other Technologies

Applications Covered:

• Diabetes Management
• Respiratory Diseases
• Cardiology
• Oncology
• Neurology
• Mental Health & Behavioral Disorders
• Other Applications

End Users Covered:

• Hospitals & Clinics
• Homecare Settings / Patients
• Ambulatory Care Centers
• Long-Term Care Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliance

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Technology Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Remote Patient Monitoring Market, By Offering

• 5.1 Introduction
• 5.2 Devices
  • 5.2.1 Wearable Devices
  • 5.2.2 Implants
  • 5.2.3 Handheld & Portable Devices
  • 5.2.4 Multi-parameter Monitors
  • 5.2.5 Special Monitors
• 5.3 Software
  • 5.3.1 On-premise Software
  • 5.3.2 Cloud-based Software
• 5.4 Services
  • 5.4.1 Setup & Integration Services
  • 5.4.2 Monitoring & Alert Services
  • 5.4.3 Training & Support
  • 5.4.4 Maintenance & Technical Support
• 5.5 Other Offerings

6 Global Remote Patient Monitoring Market, By Transmission

• 6.1 Introduction
• 6.2 Synchronous
• 6.3 Asynchronous

7 Global Remote Patient Monitoring Market, By Mode of Delivery

• 7.1 Introduction
• 7.2 Connected / Wireless Monitoring
• 7.3 Standalone Monitoring Systems

8 Global Remote Patient Monitoring Market, By Technology

• 8.1 Introduction
• 8.2 Connectivity Technology
• 8.3 Data Processing & Analytics
• 8.4 Monitoring Technology
• 8.5 Communication Technology
• 8.6 Interoperability & Integration
• 8.7 Other Technologies

9 Global Remote Patient Monitoring Market, By Application

• 9.1 Introduction
• 9.2 Diabetes Management
• 9.3 Respiratory Diseases
• 9.4 Cardiology
• 9.5 Oncology
• 9.6 Neurology
• 9.7 Mental Health & Behavioral Disorders
• 9.8 Other Applications

10 Global Remote Patient Monitoring Market, By End User

• 10.1 Introduction
• 10.2 Hospitals & Clinics
• 10.3 Homecare Settings / Patients
• 10.4 Ambulatory Care Centers
• 10.5 Long-Term Care Centers
• 10.6 Other End Users

11 Global Remote Patient Monitoring Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Welch Allyn
• 13.2 Vivify Health
• 13.3 Tunstall Healthcare
• 13.4 ResMed Inc.
• 13.5 Qardio Inc.
• 13.6 Philips Healthcare
• 13.7 Medtronic plc
• 13.8 Masimo Corporation
• 13.9 iRhythm Technologies
• 13.10 Honeywell Life Care Solutions
• 13.11 Health Recovery Solutions
• 13.12 GE HealthCare
• 13.13 Care Innovations
• 13.14 Boston Scientific Corporation
• 13.15 BioTelemetry
• 13.16 AMC Health
• 13.17 AliveCor Inc
• 13.18 Abbott Laboratories